We see the definition of “micro” getting even tinier, impacting how we look at health in three ways.
First, we know the capillaries are the largest surface organ at 10,000 square feet and the largest organ in the body at 60,000 miles end-to-end. Paradoxically, the largest organ of the body is comprised of the smallest of capillaries. With new software advancements, GlycoCheck testing technology now analyzes capillaries that are as small as 4 microns, so small that 100 of these tiny capillaries fit inside a human hair. In just minutes, 100,000 vessels are measured, with 1,000 measurements calculated per vessel with over 100 million calculations.
Second, we expect 2021 to be the year of learning more about COVID-19. It will be a change of how we view microvascular health for nearly every condition and disease known. Researchers in Europe using GlycoCheck found that COVID-19 patients who are on mechanical ventilation have lost up to 95% of those tiniest of capillaries. Those tiny micro-thin capillaries deliver oxygen and nutrients. And when the microcirculation is so severely compromised, treatments will need to revive those thousands of miles of destroyed capillaries.
And third, breakthroughs in health must include how to restore and protect those tiniest of microvessels. Microvascular Health Solutions is leading the charge with all-natural Endocalyx. Endocalyx supports the health of microcirculation and could help COVID-19 patients to reduce the damage to their capillaries. This hopefully will shorten the time with lingering COVID-19 complications. Restore those tiny capillaries, and people can return to normal life much faster.
Our prediction: the world of healthcare will be looking for big solutions that tackle huge problems with tiny blood vessels as the medical community begins to understand more and more that “micro” is getting even smaller.